This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gottschalk, B. Articles by Spellerberg, B. Search for Related Content PubMed PubMed Citation Articles by Gottschalk, B. Articles by Spellerberg, B.

Transport of Multidrug Resistance Substrates by the Streptococcus agalactiae Hemolysin Transporter

Department of Medical Microbiology and Hygiene, University of Ulm, Robert Koch Strasse 8, D-89081 Ulm, Germany

Received 25 May 2005/ Accepted 26 May 2006

Streptococcus agalactiae (group B streptococcus [GBS]) causes neonatal sepsis, pneumonia, and meningitis, as well as infections of the bovine udder. The S. agalactiae hemolysin is regarded as an important virulence factor, and hemolysin expression is dependent on the cyl gene cluster. cylA and cylB encode the ATP binding and transmembrane domains of a typical ATP binding cassette (ABC) transporter. The deduced proteins contain the signature sequence of a multidrug resistance (MDR) transporter, and mutation of the genes results in a nonhemolytic and nonpigmented phenotype. To further elucidate the function of the putative transporter, nonpolar deletion mutants of cylA were constructed. These mutants are nonhemolytic and can be complemented by the transporter genes. Wild-type strain and nonhemolytic cylA and cylK deletion mutants were exposed to known substrates of MDR transporters. Mutation of cylA significantly impaired growth in the presence of daunorubicin, doxorubicin, and rhodamine 6G and resulted in a decreased export of doxorubicin from the cells. The mutation of cylK, a gene of unknown function located downstream from cylA, caused a loss of hemolysis but had no effect on the transport of MDR substrates. Furthermore, the hemolytic activity of the wild-type strain was inhibited by reserpine in a dose-dependent manner. We conclude that CylAB closely resembles an ABC-type MDR transporter and propose that the GBS hemolysin molecule represents a natural substrate of the transporter.

This article has been cited by other articles:

• Sigge, A., Schmid, M., Mauerer, S., Spellerberg, B. (2008). Heterogeneity of Hemolysin Expression during Neonatal Streptococcus agalactiae Sepsis. J. Clin. Microbiol. 46: 807-809 [Abstract] [Full Text]  
• Vanberg, C., Lutnaes, B. F., Langsrud, T., Nes, I. F., Holo, H. (2007). Propionibacterium jensenii Produces the Polyene Pigment Granadaene and Has Hemolytic Properties Similar to Those of Streptococcus agalactiae. Appl. Environ. Microbiol. 73: 5501-5506 [Abstract] [Full Text]  
• Forquin, M.-P., Tazi, A., Rosa-Fraile, M., Poyart, C., Trieu-Cuot, P., Dramsi, S. (2007). The Putative Glycosyltransferase-Encoding Gene cylJ and the Group B Streptococcus (GBS)-Specific Gene cylK Modulate Hemolysin Production and Virulence of GBS. Infect. Immun. 75: 2063-2066 [Abstract] [Full Text]